Health Products Regulatory Authority (HPRA)
FOI Requests — 123 records (page 2 of 3)
- Received —Decided 10 April 2024Handled outside of FOIHealth Products Regulatory Authority (HPRA)
Request for information in relation to adverse reactions.
- Received —Decided 8 April 2024GrantedHealth Products Regulatory Authority (HPRA)
Request for information directly to HCP’s in relation to the HPRA raising awareness of reporting adverse reactions
- Received —Decided 8 April 2024RefusedHealth Products Regulatory Authority (HPRA)
Request for information directly to the general public in relation to the HPRA raising awareness of reporting adverse reactions
- Received —Decided 3 April 2024Part-GrantedHealth Products Regulatory Authority (HPRA)
Request for an inspection report
- Received —Decided 29 March 2024Part-GrantedHealth Products Regulatory Authority (HPRA)
Request for internal audit reports and risk register
- Received —Decided 29 March 2024WithdrawnHealth Products Regulatory Authority (HPRA)
Request for information in relation to adverse reactions.
- Received —Decided 25 March 2024GrantedHealth Products Regulatory Authority (HPRA)
Request for disclosure log
- Received —Decided 25 March 2024Handled outside of FOIHealth Products Regulatory Authority (HPRA)
Request relating to information associated with adverse reactions reports and COVID-19
- Received —Decided 19 March 2024RefusedHealth Products Regulatory Authority (HPRA)
Request relating to adverse reactions associated with a medical device
- Received —Decided 29 February 2024Part-GrantedHealth Products Regulatory Authority (HPRA)
Request for inspection report relating to a fertility clinic
- Received —Decided 29 February 2024RefusedHealth Products Regulatory Authority (HPRA)
Request relating to Enforcement activities
- Received —Decided 29 February 2024RefusedHealth Products Regulatory Authority (HPRA)
Request in relation to cosmetic report
- Received —Decided 16 February 2024RefusedHealth Products Regulatory Authority (HPRA)
Request for information in relation to a medicinal product - Iruxol Mono 1.2U/g ointment (PA22696/001/001)
- Received —Decided 31 January 2024Part-GrantedHealth Products Regulatory Authority (HPRA)
Request for minutes and correspondence between the HPRA and CHI
- Received —Decided —Seeking refinementHealth Products Regulatory Authority (HPRA)
Request for anonymised summary listing of adverse reaction regarding vaccines administered as part of the national school immunisation programme.
- Received 4 January 2023Decided —Handled outside of FOIHealth Products Regulatory Authority (HPRA)
Request for Authority meeting reports for 2022
- Received 11 January 2023Decided —WithdrawnHealth Products Regulatory Authority (HPRA)
Request for information in relation to medical devices inspections
- Received 13 January 2023Decided —Handled outside of FOIHealth Products Regulatory Authority (HPRA)
Request for information in relation to GCP inspections
- Received 1 February 2023Decided —Part-GrantedHealth Products Regulatory Authority (HPRA)
Request for information in relation to a codeine
- Received 10 February 2023Decided —Handled outside of FOIHealth Products Regulatory Authority (HPRA)
Request related to a list of questions regarding Covid-19
- Received 28 February 2023Decided —GrantedHealth Products Regulatory Authority (HPRA)
Request for information in relation to a incident reports associated with a medical device
- Received 21 February 2023Decided —Part-GrantedHealth Products Regulatory Authority (HPRA)
Request for information in relation to a Valproate
- Received 28 February 2023Decided —Part-GrantedHealth Products Regulatory Authority (HPRA)
Request for information in relation to veterinary sciences
- Received 16 March 2023Decided —GrantedHealth Products Regulatory Authority (HPRA)
Request for information in relation to a hemostatic agents
- Received 6 March 2023Decided —Handled outside of FOIHealth Products Regulatory Authority (HPRA)
Request for information in relation to veterinary sciences
- Received 10 March 2023Decided —Part-GrantedHealth Products Regulatory Authority (HPRA)
Request for information in relation to an inspection report.
- Received 13 March 2023Decided —WithdrawnHealth Products Regulatory Authority (HPRA)
Request for information in relation to a medicinal product - Rivaroxaban Clonmel 20mg hard caps PA0126/353/002
- Received 28 March 2023Decided —Health Products Regulatory Authority (HPRA)
Request for information in relation to an inspection report
- Received 27 March 2023Decided —RefusedHealth Products Regulatory Authority (HPRA)
Request for information in relation to compliance activities
- Received 4 April 2023Decided —RefusedHealth Products Regulatory Authority (HPRA)
Request for information in relation to veterinary sciences
- Received 4 April 2023Decided —Part-GrantedHealth Products Regulatory Authority (HPRA)
Request for information in relation to a Valproate
- Received 13 April 2023Decided —WithdrawnHealth Products Regulatory Authority (HPRA)
Request in relation to compliance in relation to the (Control of Advertising) regulations 2007
- Received 10 May 2023Decided —Handled outside of FOIHealth Products Regulatory Authority (HPRA)
Request for clinical studies in relation to medical product Ikorel
- Received 2 May 2023Decided —GrantedHealth Products Regulatory Authority (HPRA)
Request for information in relation to Climate Action Plans
- Received 9 May 2023Decided —GrantedHealth Products Regulatory Authority (HPRA)
Request for information in relation to the Authority report
- Received 26 June 2023Decided —Part-GrantedHealth Products Regulatory Authority (HPRA)
Request for information in relation to a medical device, lotus edge
- Received 9 June 2023Decided —Part-GrantedHealth Products Regulatory Authority (HPRA)
Request for inspection reports in relation to fertility clinics
- Received 1 June 2023Decided —Part-GrantedHealth Products Regulatory Authority (HPRA)
Request for an inspection report
- Received 20 June 2023Decided —RefusedHealth Products Regulatory Authority (HPRA)
Request for correspondence in relation to shortage of medicines in relation to Amoxicillin
- Received 3 October 2023Decided —Part-GrantedHealth Products Regulatory Authority (HPRA)
Correspondence relating to a medical device recall
- Received 25 July 2023Decided —RefusedHealth Products Regulatory Authority (HPRA)
Request relating to Enforcement activities
- Received 4 July 2023Decided —Part-GrantedHealth Products Regulatory Authority (HPRA)
Request for inspection reports
- Received 20 June 2023Decided —RefusedHealth Products Regulatory Authority (HPRA)
Request for the HPRA people strategy report
- Received 12 July 2023Decided —Part-GrantedHealth Products Regulatory Authority (HPRA)
Request for information in relation to veterinary sciences
- Received 20 June 2023Decided —TransferredHealth Products Regulatory Authority (HPRA)
Request for information in relation to activities of the HSE
- Received 12 July 2023Decided —Part-GrantedHealth Products Regulatory Authority (HPRA)
Request for information in relation to veterinary sciences
- Received 24 July 2023Decided —WithdrawnHealth Products Regulatory Authority (HPRA)
Request for inspection reports in relation to fertility clinics
- Received 4 August 2023Decided —RefusedHealth Products Regulatory Authority (HPRA)
Request for an inspection report
- Received 28 July 2023Decided —RefusedHealth Products Regulatory Authority (HPRA)
Request relating to adverse reactions associated with Covid-19 vaccine
- Received 2 August 2023Decided —RefusedHealth Products Regulatory Authority (HPRA)
Request for Authority meeting reports